This suggests that in ccRCC, lipophagy functions as a tumor-suppressive mechanism that is actively inhibited by the HIF-2α/miR-7-5p axis to maintain the lipid-rich phenotype required for tumor progression. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.